Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $254K | +4.89K | +58.97% | $51.90 | 13.2K | Nov 5, 2021 | Direct | |
transaction | CNMD | Common Stock | Sale | -$750K | -4.79K | -36.34% | $156.51 | 8.4K | Nov 5, 2021 | Direct | F1 |
transaction | CNMD | Common Stock | Sale | -$15.7K | -100 | -1.19% | $157.11 | 8.3K | Nov 5, 2021 | Direct | |
transaction | CNMD | Common Stock | Options Exercise | $235K | +3.4K | +40.97% | $69.03 | 11.7K | Nov 5, 2021 | Direct | |
transaction | CNMD | Common Stock | Sale | -$454K | -2.9K | -24.79% | $156.44 | 8.8K | Nov 5, 2021 | Direct | F2 |
transaction | CNMD | Common Stock | Sale | -$78.5K | -500 | -5.68% | $157.06 | 8.3K | Nov 5, 2021 | Direct | F3 |
transaction | CNMD | Common Stock | Options Exercise | $231K | +2.89K | +34.79% | $79.94 | 11.2K | Nov 5, 2021 | Direct | |
transaction | CNMD | Common Stock | Sale | -$373K | -2.39K | -21.34% | $156.44 | 8.8K | Nov 5, 2021 | Direct | F4 |
transaction | CNMD | Common Stock | Sale | -$78.5K | -500 | -5.68% | $156.95 | 8.3K | Nov 5, 2021 | Direct | F5 |
transaction | CNMD | Common Stock | Options Exercise | $136K | +1.84K | +22.22% | $73.94 | 10.1K | Nov 5, 2021 | Direct | |
transaction | CNMD | Common Stock | Sale | -$273K | -1.74K | -17.19% | $156.48 | 8.4K | Nov 5, 2021 | Direct | F6 |
transaction | CNMD | Common Stock | Sale | -$15.7K | -100 | -1.19% | $157.05 | 8.3K | Nov 5, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -4.89K | -100% | $0.00* | 0 | Nov 5, 2021 | Common Stock | 4.89K | $51.90 | Direct | F7 |
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -3.4K | -100% | $0.00* | 0 | Nov 5, 2021 | Common Stock | 3.4K | $69.03 | Direct | F7 |
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -2.89K | -100% | $0.00* | 0 | Nov 5, 2021 | Common Stock | 2.89K | $79.94 | Direct | F7 |
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -1.84K | -100% | $0.00* | 0 | Nov 5, 2021 | Common Stock | 1.84K | $73.94 | Direct | F8 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F7 | The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
F8 | The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |